Tracked shipping to South Africa with premium packaging for just R199 

Ship to
South Africa
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Select your country

Americas

Europe

Rest of the world

portada The Path From Biomarker Discovery to Regulatory Qualification
Type
Physical Book
Publisher
Year
2013
Language
English
Pages
206
Format
Paperback
ISBN13
9780123914965
Edition No.
1
Categories

The Path From Biomarker Discovery to Regulatory Qualification

Cheaper New Book Imported to South Africa
Delivery: 29 Sep - 08 Oct Shipping: 10 to 12 business days.
R 945
Faster New Book Imported to South Africa
Delivery: 22 Sep - 30 Sep Shipping: 5 to 6 business days.
R 1,280
R 945

Synopsis "The Path From Biomarker Discovery to Regulatory Qualification "

The Path from Biomarker Discovery to Regulatory Qualification is a unique guide that focuses on biomarker qualification, its history and current regulatory settings in both the US and abroad. This multi-contributed book provides a detailed look at the next step to developing biomarkers for clinical use and covers overall concepts, challenges, strategies and solutions based on the experiences of regulatory authorities and scientists. Members of the regulatory, pharmaceutical and biomarker development communities will benefit the most from using this book―it is a complete and practical guide to biomarker qualification, providing valuable insight to an ever-evolving and important area of regulatory science. For complimentary access to chapter 13, 'Classic' Biomarkers of Liver Injury, by John R. Senior, Associate Director for Science, Food and Drug Administration, Silver Spring, Maryland, USA, please visit the following site:  http://tinyurl.com/ClassicBiomarkers Contains a collection of experiences of different groups taking different types of biomarkers to different levels of qualification and provides insightful case studies of an important area of regulatory science Focuses on practical advice, concepts, strategies and overall outcomes to support those working toward biomarker qualification for clinical use Offers a valuable resource for members of the regulatory, pharmaceutical and biomarker development communities.

Customers reviews

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews